Global health is undergoing “transformative change” — and that change isn’t just led by pharmaceutical and medical device companies, but increasingly by a new class of companies that’ve never been seen as leaders in health.
That’s what Derek Yach, executive director of the Vitality Institute for Health Promotion, told Devex in a recent video interview.
Yacht predicts “transformative change” at the nexus of information technology and biotech, for instance, as companies begin to think more about the promotion of health, prevention of disease and improvement of quality of life rather than just the treatment of disease.
“We’ve seen the dramatic advance of public-private partnerships not just filling gaps but building on innovation and technology,” said the former WHO executive director for noncommunicable diseases and mental health.
Watch the above clip to hear Yacht’s take on the future leaders in global health.
Want to learn more? Check out the Healthy Means campaign site and tweet us using #HealthyMeans.
Healthy Means is an online conversation hosted by Devex in partnership with Concern Worldwide, Gavi, GlaxoSmithKline, International Federation of Pharmaceutical Manufacturers & Associations, International Federation of Red Cross and Red Crescent Societies, Johnson & Johnson and the United Nations Population Fund to showcase new ideas and ways we can work together to expand health care and live better lives.
About the author
Rolf RosenkranzRolfRosenkranz
Rolf Rosenkranz has worked as a Global Editor for Devex. Previously, Rolf was managing editor at Inside Health Policy, a subscription-based news service in Washington. He has reported from Africa for the Johannesburg-based Star and its publisher, Independent News & Media, as well as the Westdeutsche Allgemeine Zeitung, a German daily.